Dopesick: 1x4
Pseudo-Addiction
Sky-high OxyContin sales are threatened by reports of abuse, prosecutors investigate a claim central to OxyContin marketing, and Finnix begins to question the safety of the drug.
Links
1 - AllS01 Zip Nov. 21, 2021
1 - 1First Bottle May. 08, 2024
1 - 2Breakthrough Pain May. 08, 2024
1 - 3The 5th Vital Sign May. 08, 2024- 1 - 4Pseudo-Addiction May. 08, 2024
1 - 5The Whistleblower May. 08, 2024
1 - 6Hammer the Abusers May. 08, 2024
1 - 7Black Box Warning May. 08, 2024
1 - 8The People vs. Purdue Pharma May. 08, 2024